More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

SGLT2 inhibitors such as Jardiance and AstraZeneca’s Forxiga/Farxiga (dapagliflozin) are starting to make waves for their potential in treating chronic heart failure, but Boehringer and Lilly ...

Results from EMPA-KIDNEY are due in 2022. Jardiance is the market leader in the SGLT2 inhibitor class, ahead of AstraZeneca’s Farxiga (dapagliflozin) and Johnson & Johnson’s Invokana (canagl ...

Medicare, in collaboration with Medicaid, has negotiated with pharmaceutical companies to reduce the prices of ten high-cost, ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

LeBron James turned 40 years old Monday, and, while speaking to reporters on his birthday, admitted he never thought he'd still be playing pro basketball at this age. But here James is, on the ...

40m "I will be standing up and screaming 'superb, superb, superb'" - Indian legend's massive take on Rishabh Pant ahead of BGT 2024-25 5th Test "I will be standing up and screaming 'superb, superb ...

After hours: January 3 at 6:23:47 PM EST Loading Chart for VS ...